Stockreport

How Halozyme's ENHANZE–Vedolizumab Deal With Takeda At Halozyme Therapeutics (HALO) Has Changed Its Investment Story [Yahoo! Finance]

Halozyme Therapeutics, Inc.  (HALO) 
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: halozyme.com/investors/default.aspx
PDF delivery technology for use with vedolizumab, an inflammatory bowel disease therapy marketed as ENTYVIO. This deal deepens Halozyme's role in subcutaneous delivery of [Read more]